BioSpace News Archive

Amolyt Pharma, a global clinical-stage company specialized in developing therapeutic peptides for rare endocrine and metabolic diseases, today announced that the first subject in the Phase 1 clinical trial for AZP-3601 has been dosed.

Two clinical trial sites activated in Turkey, with patient screening initiated Follows activation of six clinical sites in Hungary and dosing of first eight patients Topline data expected in Q2 2021 NEW YORK, Oct. 14, 2020 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that it has activated two trial sites in

Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics to reactivate mutant tumor suppressor protein, p53, today announced the launch of p53reactivation.com.

RAPT Therapeutics, Inc. (Nasdaq: RAPT), today announced the addition of preeminent oncology thought leaders, Lisa Butterfield, Ph.D. and Lawrence Fong, M.D., to its Scientific Advisory Board.

AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) announces a non-brokered private placement of up to 15,000,000 units (“Units”) at a price of $0.10 per unit for gross proceeds of $1,500,000.

-- Is Oral Testosterone a Potential Treatment for COVID-19 in Men? -- TLANDO™, Oral Testosterone Replacement Therapy Without Dose Titration Requirement

Quest Analytics today announced that Barbara Dumery will join the leadership team as Chief Product Officer

Sleep aids refer to those medical devices and drugs that are utilized in the diagnosis and treatment of various types of sleep disorders, including insomnia and sleep apnea.

Since the last decade, technologies and techniques for rapid sequencing of human genomes have made incredible strides.

Polyphor AG, announced that it has received a new and second non-dilutive funding award from CARB-X, a global partnership led by Boston University dedicated to supporting the development of antibacterial products, to diagnose, prevent and treat drug-resistant infections.